医学
药品
重症监护医学
梅德林
药理学
政治学
法学
出处
期刊:Current Opinion in Critical Care
[Ovid Technologies (Wolters Kluwer)]
日期:2024-09-16
标识
DOI:10.1097/mcc.0000000000001210
摘要
The aim of this review is to provide a discussion of new perspectives for up-to-date definitions, a contemporary classification system, and the potential role of stress and damage biomarkers in the context of drug related kidney diseases and disorders.
科研通智能强力驱动
Strongly Powered by AbleSci AI